GlassScriptPhysician profile
Mathew Resnick
NPI 1679934210
$4,243.58
in general payments reported to CMS, 2019-2025
7 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $126 · 2023: $301 · 2024: $3,816.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,557 · Food and Beverage: $1,514 · Education: $46.78.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,556.51 |
| Food and Beverage | $1,513.81 |
| Education | $46.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $2,341.23 | 2023-2024 | Oxford, Persona, Rosa |
| Medical Device Business Services, INC. | $1,409.03 | 2024 | |
| Depuy Synthes Sales INC. | $209.53 | 2024 | Truespan Orthocord, Healix Knotless Peek |
| Medtronic, INC. | $126.48 | 2022 | |
| Davol INC. | $76.70 | 2024 | Arista Ah Flexitip |
| Stryker Corporation | $59.02 | 2024 | Accolade, Triathlon, Insignia |
| Regeneron Healthcare Solutions, INC. | $21.59 | 2023 | Dupixent |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mathew Resnick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.